DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09606 DUALITYBIO-B

Closed 09-08 16:08:36

186.600

+6.600

+3.67%

High188.900	Low175.100	Vol1.06M
Open181.200	D1 Closing180.000	Amplitude7.67%
Mkt Cap16.95B	Tradable Cap16.95B	Total Shares90.83M
T/O195.40M	T/O Rate1.17%	Tradable Shares90.83M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":186.6,"timestamp":1788854916011,"preClose":180,"halted":0,"volume":1064728,"delay":0,"changeRate":0.03666666666666663,"floatShares":90833600,"shares":90833600,"eps":-46.53491887992346,"marketStatus":"Closed","change":6.6,"latestTime":"09-08 16:08:36","open":181.2,"high":188.9,"low":175.1,"amount":195404464,"amplitude":0.076667,"askPrice":186.7,"askSize":500,"bidPrice":186.6,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":-18.84095857248269,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788917400000},"marketStatusCode":5,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":180,"openAndCloseTimeList":[[1788831000000,1788840000000],[1788843600000,1788854400000]],"volumeRatio":1.269087,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"1117650890","title":"DUALITYBIO-B: DualityBio Ltd. Acquires Shares, Long Position Rises to 7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117650890","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117650890?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:52","pubTimestamp":1788861177,"startTime":"0","endTime":"0","summary":"DualityBio Ltd. bought 10,000 shares of DUALITYBIO-B stock at an average of HKD 174.054 per share on September 2, 2026, involving about HKD 1.74 million.Prior to the acquisition, DualityBio Ltd.'s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131492576","title":"Duality Biotherapeutics, Inc. - B: DualityBio Ltd. Acquires Shares, Long Position Rises to 7.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131492576","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131492576?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:17","pubTimestamp":1788859037,"startTime":"0","endTime":"0","summary":"On September 3, 2026, DualityBio Ltd. bought 10,000 shares of Duality Biotherapeutics, Inc. - B (09606) at an average of HKD 184.149 per share, involving about HKD 1.84 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108142102","title":"Hong Kong Stock Movement | DUALITYBIO-B (09606) Climbs Over 4% in Late Trading, New BD Breakthrough with Roche, Potential Milestone Payments Exceed $1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1108142102","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108142102?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:04","pubTimestamp":1788854659,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its stock price surge more than 4% during the late trading session, with the company announcing a new business development collaboration with Genentech, a member of the Roche...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","VXUS","HK0000252152.HKD","HK0000252160.HKD","BK4585","09606","BK4588","HK0000500386.USD","BK1161","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115148072","title":"Chairman and CEO Acquires Additional Shares in DualityBio Over Two Consecutive Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=1115148072","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115148072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:40","pubTimestamp":1788781220,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange reveals that from September 2 to 3, Chairman and Chief Executive Officer Zhu Zhongyuan increased his stake in 映恩生物-B (09606) on two successive trading days.The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK1161","HK0000252160.HKD","09606","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126155128","title":"DUALITYBIO-B: Zhu Zhongyuan Acquires Shares, Long Position Rises to 17.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126155128","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126155128?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:13","pubTimestamp":1788772384,"startTime":"0","endTime":"0","summary":"On September 3, 2026, Zhu Zhongyuan bought 10,000 shares of DUALITYBIO-B (09606) stock at an average of HKD 184.149 per share, involving about HKD 1.84 million.Prior to the acquisition, Zhu...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144600263","title":"DUALITYBIO-B (09606) Surges 6% in Afternoon Trade as BD Deals Exceed $7 Billion and Company Eyes US Development Role","url":"https://stock-news.laohu8.com/highlight/detail?id=1144600263","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144600263?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:04","pubTimestamp":1788419059,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its share price climb more than 6% during Tuesday's afternoon trading session, buoyed by investor optimism surrounding its expanding partnership portfolio. The stock was last...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","HK0000500386.USD","BK4588","BK1161","LU2543165471.USD","KCAI","09606","HK0000252160.HKD","VXUS","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129949172","title":"Movement Alert｜DUALITYBIO-B Rises 5.45% in Regular Trading, Multiple Brokers Maintain Buy Ratings Triggering Oversold Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1129949172","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129949172?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:30","pubTimestamp":1788417026,"startTime":"0","endTime":"0","summary":"On September 3, DUALITYBIO-B rose 5.45% in regular trading, trading at HK$185.9 per share, with turnover of HK$123 million. The rally was primarily driven by a cluster of bullish institutional...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"DualityBio-B Rebounds as CMB International Keeps Buy Rating","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083997","title":"DualityBio Signs Genentech ADC Collaboration, Secures USD 45 Million Upfront, over USD 1 Billion Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083997","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083997?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:26","pubTimestamp":1788247561,"startTime":"0","endTime":"0","summary":"DualityBio signs Genentech ADC collaboration, secures USD 45 million upfront, over USD 1 billion milestonesPortfolio company DualityBio signed a global collaboration, licensing deal with Roche unit Ge","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4MpYtQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","HK0000252160.HKD","09606","BK1161","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157515463","title":"Movement Alert｜DUALITYBIO-B Falls 7.29% in Regular Trading, H1 Revenue Plunges as Adjusted Net Profit Swings to Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1157515463","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157515463?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:06","pubTimestamp":1788159976,"startTime":"0","endTime":"0","summary":"On August 31, DUALITYBIO-B fell 7.29% in regular trading, trading at 185.5 HKD/share, with turnover of HKD 282 million. The selloff came as the market digested the company's disappointing interim...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"DUALITYBIO-B Plunges as Adjusted Net Profit Swings to Loss","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045587","title":"Duality Biotherapeutics (SEHK:9606) Stock Grapples With Revenue Collapse And Heavy Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045587","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663045587?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:37","pubTimestamp":1788050276,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics just reminded investors what high conviction in early stage oncology really looks like. The stock closed at HK$200.2 on the day of the H1 2026 release, with the market reacting to a story that is still all about scale of losses rather than clean profitability. The headline is simple. Revenue sat at ¥219.33 million for the half, while the company booked a net loss of ¥917.55 million and a basic loss per share of ¥10.2.\nFor a company often framed as a long term growth...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-sehk9606-stock-grapples-with-revenue","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-sehk9606-stock-grapples-with-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","LU2543165471.USD","09606","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662018061","title":"Duality Biotherapeutics Inc - Board Does not Recommend Payment of Interim Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2662018061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662018061?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:35","pubTimestamp":1787913328,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P10A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2543165471.USD","HK0000252160.HKD","09606","BK1161","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061058","title":"Duality Biotherapeutics, Inc Hy Adjusted Loss Rmb626.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061058?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:34","pubTimestamp":1787913284,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLXR1NRTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061057","title":"Duality Biotherapeutics FY26 H1 Loss Narrows to RMB 917.55 Million; Revenue Drops 82.16% to RMB 219.33 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061057","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061057?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:34","pubTimestamp":1787913245,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics FY26 H1 loss narrows to RMB 917.55 million; revenue drops 82.16% to RMB 219.33 millionDuality Biotherapeutics posted revenue of RMB 219.33 million for the six months ended June","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2TQR06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","BK1161","09606","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685460","title":"Duality Biotherapeutics Ties Up With Genentech to Develop Oncology Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685460","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685460?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:46","pubTimestamp":1787906779,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics  partnered with Roche Group's Genentech to develop oncology drugs based on the DualityBio Unique Payload Antibody Conjugate platform, according to a Friday disclosure on the Hong Kong bourse.The Hong Kong-listed biotherapy company will receive an upfront payment of $45 million as part of the deal, as well as milestone payments of over $1 billion.Duality will also receive tiered royalty payments on annual net sales of products approved from the partnership.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","09606","BK1161","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056343","title":"Duality Biotherapeutics Rises Most in Near Six Weeks on Roche's Genentech Tie-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056343","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056343?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:53","pubTimestamp":1787892800,"startTime":"0","endTime":"0","summary":"BUZZ-Duality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up** Shares of Duality Biotherapeutics Inc9606.HKrise 6.3% to HK$207.8, on track for biggest one-day pctadvancesince July 20** Stock hit the highest level since August 11** Duality said it entered into a collaboration and license agreement with Roche Group's Genentech Inc to develop next-generation antibody-drug conjugates  targeting certain oncology indications** Duality will lead discovery and early global clinical development while Genentech will obtain an exclusive worldwide license to the resulting collaboration ADCs** Duality will receive an upfront payment of $45 million and will be eligible to receive potential development, regulatory and commercial milestone payments ofmore than $1 billionacross all collaboration programs** HK-listed company says it will be entitled to receive tiered royalty payments on annual net sales of approved products arising from the collaboration** YTD, stock down 30.7%,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","HK0000252160.HKD","09606","HK0000252152.HKD","BK1161","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662314055","title":"Dualitybio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation Adcs Built on Dualitybio's Dupac Novel-Payload Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662314055","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662314055?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:09","pubTimestamp":1787890143,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA6KBFRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09606","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106015884","title":"DUALITYBIO-B Surges Nearly 6% Following Genentech Licensing Pact","url":"https://stock-news.laohu8.com/highlight/detail?id=1106015884","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106015884?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:51","pubTimestamp":1787889103,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its share price climb nearly 6% during the morning trading session. As of the latest update, the stock was up 5.78% at HK$206.80, with trading turnover reaching HK$108...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","LU2543165471.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166382217","title":"Movement Alert｜DUALITYBIO-B Rises 5.27% in Regular Trading, Signs Global ADC R&D Collaboration with Genentech Securing $45M Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1166382217","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166382217?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:34","pubTimestamp":1787880889,"startTime":"0","endTime":"0","summary":"On August 28, DUALITYBIO-B rose 5.27% in regular trading, trading at 204.0 HKD/share, with turnover of approximately 28.91 million HKD. The rally was driven by the announcement of a global research,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"DUALITYBIO-B Gains on $45M Genentech ADC Deal and UBS Buy","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108068616","title":"Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=1108068616","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108068616?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:12","pubTimestamp":1787879553,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) has received approval from China's National Medical Products Administration for Elenestinib (futibatinib) to treat patients with FGFR2 fusion/rearrangement intrahepatic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02273","HK0000252160.HKD","BK1161","02097","BK4588","HK0000500386.USD","HK0000252152.HKD","LU2460026573.USD","BK1588","BK1233","VXUS","LU2543165471.USD","BK1191","02005","KCAI","BK1587","BK1219","BK1616","BK4585","00013","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111197255","title":"DUALITYBIO-B Inks Landmark Global ADC Collaboration with Roche's Genentech Using Proprietary DUPAC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1111197255","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111197255?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:02","pubTimestamp":1787875336,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) has announced the signing of a collaboration and license agreement with Genentech, Inc., a member of the Roche Group, dated August 27, 2026. The partnership leverages...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000500386.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0702},{"period":"3month","weight":0.0321},{"period":"6month","weight":-0.4075},{"period":"1year","weight":-0.5044},{"period":"ytd","weight":-0.3964}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0345},{"period":"6month","weight":-0.0188},{"period":"1year","weight":-0.0002},{"period":"ytd","weight":-0.0085}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Duality Biotherapeutics Inc is an investment holding company principally engaged in clinical-stage biopharmaceuticals. The Company is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The Company's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The Company's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The Company principally conducts its businesses in domestic and overseas markets.","exchange":"SEHK","name":"DUALITYBIO-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DUALITYBIO-B,09606,DUALITYBIO-B股票,DUALITYBIO-B股票老虎,DUALITYBIO-B股票老虎国际,DUALITYBIO-B行情,DUALITYBIO-B股票行情,DUALITYBIO-B股价,DUALITYBIO-B股市,DUALITYBIO-B股票价格,DUALITYBIO-B股票交易,DUALITYBIO-B股票购买,DUALITYBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}